lipoxin a4 has been researched along with 2019 Novel Coronavirus Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, UN | 1 |
| Lee, CH | 1 |
| Amar, Y; Archambault, AS; Boilard, É; Cheikh, A; Côté, A; Doré, É; Dubuc, I; El Hassani, A; Fares, H; Flamand, L; Flamand, N; Flamand, O; Laviolette, M; Martin, C; Rakotoarivelo, V; Tijani, Y; Turcotte, C; Zaid, Y | 1 |
| Bazan, HEP; Bazan, NG; Calandria, J; Do, KV; He, J; Kakazu, AH; Lam, TF; Nshimiyimana, R; Petasis, NA; Pham, TL | 1 |
2 review(s) available for lipoxin a4 and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Essential Fatty Acids and Their Metabolites in the Pathobiology of Inflammation and Its Resolution.
Topics: Animals; COVID-19; Dinoprostone; Fatty Acids, Essential; Humans; Inflammation; Leukotriene B4; Lipoxins; SARS-CoV-2 | 2021 |
Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm.
Topics: Animals; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Fatty Acids, Unsaturated; Humans; Lipoxins; Receptors, G-Protein-Coupled | 2021 |
1 trial(s) available for lipoxin a4 and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients.
Topics: Adult; COVID-19; Female; Humans; Leukotriene B4; Leukotriene E4; Lipoxins; Lung; Male; Middle Aged; SARS-CoV-2 | 2021 |
1 other study(ies) available for lipoxin a4 and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea.
Topics: Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Cellular Senescence; Corneal Injuries; COVID-19; Cytokines; Disease Models, Animal; Docosahexaenoic Acids; Drug Discovery; Epithelial Cells; Epithelium, Corneal; Humans; Lipoxins; Male; Protein Binding; Protein Domains; Rats; Rats, Sprague-Dawley; SARS-CoV-2; Signal Transduction; Spike Glycoprotein, Coronavirus; Virus Attachment; Virus Internalization | 2021 |